Fangfang Yan

6PUBLICATIONS

13CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsGenome structure and regulation

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 09, 2026

Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma.

|Jan 27, 2024

Single-cell multiomics decodes regulatory programs for mouse secondary palate development.

Fangfang Yan, Akiko Suzuki, Chihiro Iwaya

|Nov 03, 2023

Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins.

Yijing Li, Heng-Huan Lee, Vivian Changying Jiang

|May 31, 2023

Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma.

Yuxuan Che, Yang Liu, Yijing Li

|Jul 01, 2022

Spatiotemporal MicroRNA-Gene Expression Network Related to Orofacial Clefts.

F Yan, L M Simon, A Suzuki

|Nov 25, 2020

A developmental stage-specific network approach for studying dynamic co-regulation of transcription factors and microRNAs during craniofacial development.

Fangfang Yan, Peilin Jia, Hiroki Yoshioka

Pageof 1

Frequent Collaborators

Junichi Iwata

Zhongming Zhao

Yang Liu

Michael Wang

Akiko Suzuki

Yixin Yao

Peilin Jia

Hiroki Yoshioka

Heng-Huan Lee

Jingling Jin

Frequent Collaborators

Junichi Iwata

Zhongming Zhao

Yang Liu

Michael Wang